Industry & Business

Amneal to create up to 300 jobs in Tipperary

Amneal to create up to 300 jobs in Tipperary

Amneal to create up to 300 jobs in Tipperary
July 31
08:48 2015

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 jobs in Tipperary following its acquisition of the former Johnson & Johnson plant in Cashel.
The 200,000 square foot facility was sold to Amneal by Singapore-based investment firm Solidus Private Equity. The former Johnson & Johnson plant had been vacant for four years before being acqured by Solidus earlier this year.
Amneal said the Cashel site will be dedicated to R&D and production of metered dose and dry powder inhalers as well as biosimilars .
Amneal co-chief executive Chintu Patel said the company expects to hire an estimated 250-300 employees at full build-out.
“Our new Ireland facility is critical to Amneal’s long-term global growth, in Europe, the US and throughout the world,” he added.
IDA Ireland chief executive Martin Shanahan said regional development is a core part of the agency’s strategy.
“This announcement is great news for Tipperary and the whole of the South East region. That Amneal has chosen to locate in a facility that had been occupied previously is especially pleasing,” he added.
From its start in 2002 as a contract drug manufacturer, Amneal has grown dramatically to its current position as the 7th largest US generics supplier by volume.

About Author



Related Articles

New Subscriber

[contact-form-7 id=”65829″ title=”Subscriber”]


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events